Observational studyHuman vaccines & immunotherapeutics2020

Immunogenicity and safety after the third vaccination with the 23-valent pneumococcal polysaccharide vaccine in elderly patients with chronic lung disease.

Nobuharu Ohshima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.